Materials and methods for the treatment of depression

Details Materials and methods for the treatment of depression Materials and methods for the treatment of depression

2007-08-14

2007-08-14

Zucker, Paul A. (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S538000, C514S426000, C514S331000, C548S566000, C548S569000, C546S232000, C544S098000, C560S035000

Reexamination Certificate

active

10931586

ABSTRACT:
The subject invention provides compounds which are easily metabolized by the metabolic drug detoxification systems. Particularly, fluvoxamine analogs which have been designed to include esters within the structure of the compounds are taught. Also provided are methods of treating depression and affective disorders, such as obsessive compulsive disorder. Pharmaceutical compositions of the fluvoxamine analogs are also taught.

REFERENCES:
patent: 4085225 (1978-04-01), Welle et al.
patent: 5686447 (1997-11-01), Shutske et al.
patent: 5770740 (1998-06-01), Shutske et al.
patent: 6469064 (2002-10-01), Druzgala
patent: 6809116 (2004-10-01), Druzgala
patent: 1533063 (1978-11-01), None
patent: 7610399 (1978-03-01), None
Boshman, Theodorus A.C and Marius L. De Winter “In vitro inhibition of ADP-induced platelet aggregation by O-(aminoalkul) oxime ethers”Eur. J Med. Chem.—Chimca Therapeutica, Jul.-Aug. 1980, vol. 15, No. 4, pp. 351-356.

Affiliated with

Also associated with

Rating

Materials and methods for the treatment of depression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Materials and methods for the treatment of depression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Materials and methods for the treatment of depression will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3888931